|  Help  |  About  |  Contact Us

Publication : IL-17/CXCL5 signaling within the oligovascular niche mediates human and mouse white matter injury.

First Author  Xiao G Year  2022
Journal  Cell Rep Volume  41
Issue  12 Pages  111848
PubMed ID  36543124 Mgi Jnum  J:340920
Mgi Id  MGI:7424691 Doi  10.1016/j.celrep.2022.111848
Citation  Xiao G, et al. (2022) IL-17/CXCL5 signaling within the oligovascular niche mediates human and mouse white matter injury. Cell Rep 41(12):111848
abstractText  Cerebral small vessel disease and brain white matter injury are worsened by cardiovascular risk factors including obesity. Molecular pathways in cerebral endothelial cells activated by chronic cerebrovascular risk factors alter cell-cell signaling, blocking endogenous and post-ischemic white matter repair. Using cell-specific translating ribosome affinity purification (RiboTag) in white matter endothelia and oligodendrocyte progenitor cells (OPCs), we identify a coordinated interleukin-chemokine signaling cascade within the oligovascular niche of subcortical white matter that is triggered by diet-induced obesity (DIO). DIO induces interleukin-17B (IL-17B) signaling that acts on the cerebral endothelia through IL-17Rb to increase both circulating and local endothelial expression of CXCL5. In white matter endothelia, CXCL5 promotes the association of OPCs with the vasculature and triggers OPC gene expression programs regulating cell migration through chemokine signaling. Targeted blockade of IL-17B reduced vessel-associated OPCs by reducing endothelial CXCL5 expression. In multiple human cohorts, blood levels of CXCL5 function as a diagnostic and prognostic biomarker of vascular cognitive impairment.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

19 Bio Entities

Trail: Publication

0 Expression